A new Alzheimer's drug gave patients hope. Millions can't get it.

Time

10 February 2023 - Jay Reinstein, a former assistant city manager in Fayetteville, NC who was diagnosed with Alzheimer’s disease in 2018, finally got some good news recently. His doctor told him he would be a good candidate for the newly approved drug lecanemab (Leqembi). 

He’s in the early stages of the neurodegenerative condition, which is when the drug appears to be the most effective.

Read Time magazine article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Market access